1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Australian Oilseeds Holdings received a Nasdaq notice that its share price has been below the $1.00 minimum for 30 consecutive business days, with until November 24, 2025 to regain compliance. For the quarter ended March 31, 2025, sales revenue rose 49.8% to A$9.4 million, but the company swung to a net loss of A$0.6 million from net income of A$41 thousand a year earlier.
Nasdaq bid price notice received May 27, 2025; 180 calendar days, to November 24, 2025, to regain compliance with the $1.00 minimum
Sales revenue up 49.8% to A$9.4 million; retail oil revenue up 69.4% to A$4.7 million
Net loss of A$0.6 million versus net income of A$41 thousand in the prior-year quarter
Effective May 22, 2025, JSKS Enterprises, controlled by CEO Gary Seaton, converted about A$5 million of loans into 4,452,479 shares at $0.7241 per share
Cardio Diagnostics Holdings received written notice from Nasdaq on May 28, 2025, that it has regained compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The closing bid price was $1.00 or greater for the 10 consecutive business days from May 13 through May 27, 2025. The notice removes the risk of delisting that had been pending under the extended compliance period ending June 2, 2025.
Nasdaq notice dated May 28, 2025 confirms regained compliance with the minimum bid price rule (Listing Rule 5550(a)(2)).
Compliance is based on closing bid prices of $1.00 or greater from May 13, 2025 through May 27, 2025.
The company had been given until June 2, 2025 to regain compliance, following an initial December 2, 2024 deadline.
The non-compliance notice was first received on June 3, 2024.
Pathward Financial received a Nasdaq notice on May 22, 2025, saying it is not in compliance with listing rules because it did not timely file its quarterly report for the period ended March 31, 2025. The company needs more time to evaluate the presentation and accounting of certain third-party lending and servicing relationships. Nasdaq says the notice has no immediate effect on the listing or trading of the common stock, but the company must still regain compliance, which may take until November 11, 2025.
Nasdaq notice dated May 22, 2025, cites Listing Rule 5250(c)(1) for failure to timely file the Form 10-Q for the quarter ended March 31, 2025
Review covers third-party lending and servicing relationships in the Consumer Solutions business, within held-for-investment loan balances of approximately $280 million as of December 31, 2024
Company has 60 days from the notice date to submit a compliance plan; Nasdaq may grant up to 180 calendar days, or until November 11, 2025
Nasdaq says the notice has no immediate effect on the listing or trading of the common stock
On May 21, 2025, Tandem Diabetes and Roche entities agreed to settle all patent disputes over the t:slim X2 pump, terminating pending actions before Unified Patent Court divisions in France and Germany. The Tandem entities will pay $36 million over five years, starting with an $8 million initial payment, and the parties granted each other 10-year licenses to insulin delivery patents. The same day, shareholders elected all eight directors, approved executive pay on an advisory basis, and ratified Ernst & Young as auditor.
Settlement resolves disputes over the t:slim X2 pump and two Roche-related EP patents, ending pending actions in France and Germany.
Tandem entities will pay $36 million over five years: an $8 million initial payment, then four equal annual installments.
Cross-licenses of insulin delivery system patents run for 10 years from the May 21, 2025 effective date.
At the May 21, 2025 annual meeting, executive pay was approved with 54,337,934 for and 1,598,126 against, and shareholders chose an annual say-on-pay vote.
On May 16, 2025, a U.S. District Court in Delaware ruled in Acadia's favor on both infringement and validity in its '721 formulation patent case over Nuplazid (pimavanserin) against Aurobindo and MSN. The same week, Acadia agreed to a 12-year, two-month lease for about 52,771 square feet in Princeton, New Jersey, and will end its current 502 Carnegie Center lease after the new lease begins.
Court ruling date: May 16, 2025, in the U.S. District Court for the District of Delaware, covering both infringement and validity arguments
Defendants in the patent case: Aurobindo Pharma Limited and its affiliate, and MSN Laboratories Private Ltd. and its affiliate
210 Lease: about 52,771 square feet, term of 12 years and 2 months, commencing no later than January 1, 2026, with first-year payment of $1,899,756
Maximum landlord contribution of $5,277,100 for improvements, with a possible $2,638,550 supplemental contribution repayable with 8.00% interest
Coinbase disclosed a material cybersecurity incident in which an unknown threat actor obtained customer account data and internal documents by paying contractors and employees in support roles outside the United States. The company preliminarily estimates expenses of $180 million to $400 million for remediation and voluntary customer reimbursements, and says the full impact is still being assessed, which matters to shareholders because the cost range is large and could change.
Threat actor emailed Coinbase on May 11, 2025, demanding money in exchange for not disclosing the data; the company says it has not paid.
Exposed data reportedly includes names, contact details, masked Social Security and bank account numbers, government ID images, and account balance and transaction history.
Preliminary expense estimate of approximately $180 million to $400 million, before potential losses, indemnification claims, and recoveries.
Company says customer funds and passwords or private keys were not compromised and it is cooperating with law enforcement.
Nucor disclosed a cybersecurity incident involving unauthorized third-party access to certain of its information technology systems and said it has notified federal law enforcement. As a precaution, the company temporarily halted certain production operations at various locations and is now restarting them, while the investigation continues and the company monitors the incident's timing and materiality.
Unauthorized third-party access to certain IT systems; company activated its incident response plan and took affected systems offline
Certain production operations at various locations were temporarily and proactively halted; restart is in progress
Company is investigating with external cybersecurity experts and has notified federal law enforcement
Filing gives no dollar estimate of costs or financial impact; the company says it will continue to monitor materiality
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.